Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties

Sangivamycin is a nucleoside analog that is well tolerated by humans and broadly active against phylogenetically distinct viruses, including arenaviruses, filoviruses, and orthopoxviruses. Here, we show that sangivamycin is a potent antiviral against multiple variants of replicative severe acute res...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, Ryan P., Postnikova, Elena N., Eaton, Brett P., Cai, Yingyun, Yu, Shuiqing, Smith, Charles O., Liang, Janie, Zhou, Huanying, Kocher, Gregory A., Murphy, Michael J., Smith, Harold C., Kuhn, Jens H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765048/
https://www.ncbi.nlm.nih.gov/pubmed/34807849
http://dx.doi.org/10.1172/jci.insight.153165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765048/
https://www.ncbi.nlm.nih.gov/pubmed/34807849
http://dx.doi.org/10.1172/jci.insight.153165

Ejemplares similares